Navigation Links
Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
Date:8/31/2011

SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:


  • Stifel Nicolaus 2011 Healthcare ConferenceDate:  

    Wednesday, September 7, 2011Time:  

    1:30pm Eastern Time (10:30am Pacific Time)Place:  

    Four Seasons Hotel in BostonSpeaker:

    Scott Byrd, SVP & Chief Commercial Officer


  • UBS Global Life Sciences ConferenceDate:  

    Tuesday, September 20, 2011Time:  

    11:30am Eastern Time (8:30am Pacific Time)Place:  

    Grand Hyatt Hotel in New York CitySpeaker:

    Ted Schroeder, President & CEO


  • JMP Securities Healthcare ConferenceDate:Wednesday, September 28, 2011Time:9:30am Eastern Time (6:30am Pacific Time)Place:

    The St. Regis Hotel in New York CitySpeaker:

    Ted Schroeder, President & CEOEach presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page.  A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

    About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.Contacts:

    William R. LaRue

    SVP, CFO

    Cadence Pharmaceuticals, Inc.

    858-436-1400
    '/>"/>


  • SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
    2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
    3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
    4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
    5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
    6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
    7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
    8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
    9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
    10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/2/2016)... YORK , December 2, 2016 ... the trading session in red, while the Dow Jones Industrial ... at the close of US markets, which prompted Stock-callers this ... stocks: NuVasive Inc. (NASDAQ: NUVA ), Smith & ... (NASDAQ: NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
    (Date:12/2/2016)... LONDON , Dec. 1, 2016 Around ... every country, region and each habitable land present over ... haunt every individual once in a life time this ... proper care available until now. Given the steady increase ... mortality, together with the spiraling healthcare costs of treatment, ...
    (Date:11/30/2016)... Research and Markets has announced the addition ... - MedCore" report to their offering. ... , , The cerebrospinal fluid ... healthy individuals, it is circulated though the brain and its ventricles, the ... of CSF surrounding the brain changes significantly. As ...
    Breaking Medicine Technology:
    (Date:11/30/2016)... ... November 30, 2016 , ... "I hate when the mixture ... brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that there had ... handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and toothpaste from ...
    (Date:11/30/2016)... FL (PRWEB) , ... November 30, 2016 , ... ... disorder and mental health treatment has announced the opening of a new eating ... partial hospitalization and intensive outpatient treatment for adults and adolescents, both males and ...
    (Date:11/30/2016)... , ... November 30, 2016 , ... ... injured workers have been a focus of public policymakers and system stakeholders in ... Institute (WCRI) released its Medical Price Index for Workers’ Compensation, Eighth Edition ...
    (Date:11/30/2016)... ... November 30, 2016 , ... ... clinical research community that the FDA Binding Guidance goes into effect next month. ... formats listed in the FDA Data Standards Catalog. The current FDA Data Standards ...
    (Date:11/30/2016)... ... 2016 , ... U.S. Security Associates (USA) announced the acquisition ... Richmond, Virginia. The acquisition further strengthens USA’s capabilities within the expanding healthcare ... prides itself on 100% client-retention to the healthcare industry. In addition, ODS has ...
    Breaking Medicine News(10 mins):